ArticleGene therapy2023

Engineered AAV8 capsid acquires heparin and AVB sepharose binding capacity but has altered in vivo transduction efficiency.

Laura P van Lieshout et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.